Millions of people in the US and around the world receive drugs or treatments every year that they never actually take. A lot of prescriptions don’t lead to treatment, even when doctors are careful about what they do. This situation is known as prescription abandonment or primary non-adherence. This early gap in the care journey is bad for patients’ health, costs more than it should, and lowers the overall quality of healthcare.
How common is primary non-adherence?
IQVIA’s recent data reveals that 27% of new prescriptions in the U.S. remain unfilled. This is because some patients don’t pick them up, and some payers refuse to pay for them. According to Surescripts, almost 98 million new prescriptions were never picked up, and in one survey, 1 in 5 patients said that they had not filled a prescription, and 1 in 10 reported splitting or skipping doses because of the cost.
These early abandonment events are different from traditional non-adherence, which is when someone skips doses or stops therapy later. They show that someone didn’t even start treatment, which can have immediate clinical effects.
A doctor assumes that they have provided care when they write a prescription. But there is a vulnerable time between the prescription pad and the first dose when patients decide to forgo picking up the drug at the pharmacy and decline to start the therapy. This early abandonment is different from ongoing non-adherence and has its own set of causes and effects.
Important Reasons for Abandonment Before the First Dose
- Financial challenges
The most reliable predictor of abandonment is cost. Patients are less likely to fill prescriptions when they have to pay high co-pays and deductibles:
The IQVIA Institute for Human Data Science reported that 69% of patients do not fill their prescriptions when they have to pay more than $250.
Studies indicate that higher co-pays make it much more likely that people will stop taking their medicine. For example, people who paid $50 in co-pays were almost four times more likely to stop taking their medicine than people who paid $10 or less. Insulin and proton-pump inhibitors (PPIs) are two types of medications that have higher abandonment rates than other types. This is probably because they are expensive and require a long-term commitment.
- Issues with insurance
Not all prescriptions make it to the patient without a hitch. Because of formulary restrictions, prior authorizations, or step therapy requirements, insurance companies can often refuse to cover prescriptions. This is a big reason why a lot of prescriptions don’t get filled.
- Lack of transparency
Patients often don’t know how to get their medicine, especially if the instructions are hard to follow or they don’t know how much it will cost, what other options they have, or what pharmacies they can go to. Patients may stop taking a prescribed drug if they don’t understand why they’re taking it, its side effects, or if their insurance covers it.
- Problems with logistics
People who live in rural areas or those with few doctors have even more problems. People stop taking their medications, even if they’re cheap or covered, because they can’t get to pharmacies easily.
What are the clinical effects of premature discontinuation
Not starting prescribed therapy, especially for chronic or high-risk conditions, can have real clinical effects:
- Cardiovascular medications: In some classes, more than 25–30% of people don’t take their cardiometabolic drugs as prescribed.
- Progression of chronic diseases: If you don’t start taking medicine for high blood pressure, diabetes, or dyslipidemia right away, the risk of complications goes up quickly.
- Costs of hospitalizations: More research shows that not following through with treatment, including stopping treatment, leads to more hospitalizations and higher healthcare costs.
Why Abandoning the First Dose Is a Different Problem
Primary non-adherence is different from later non-adherence (skipping a refill or stopping early) because it happens before the patient takes any medication. Providers can’t see it most of the time because:
- If the prescription is never sent to insurance, there may not be any claim data.
- EMRs might show unfilled prescriptions only if they have access to pharmacy data.
- Patients might not tell their doctors that they are abandoning them.
But a lot of people don’t fill their prescriptions: about one in four new prescriptions go unfilled, and the rates are even higher for younger adults and people who don’t have enough insurance.
The Importance of Digital Tools and Care Coordination
To close the therapy access gap, you need to keep an eye on things and take action, such as:
Tracking Abandonment in Real Time
Solutions like Surescripts First-Fill Abandonment let care teams know when a prescription isn’t filled, so they can quickly reach out to fix any problems.
Getting Patients Involved Early
Systems that automatically follow up with patients by phone, text message, or apps can help clear up confusion, make costs clear, and encourage pickup.
Help with money and being honest about it
Giving patients real-time cost estimates and signing them up for copay assistance or patient assistance programs makes it easier for them to pay and stay in treatment.
Putting the Care Team Together
Connected workflows between providers, pharmacies, and support teams make sure that abandonment triggers coordinated action before gaps get bigger.
Supporting patients: From Prescription to Treatment
To improve real-world outcomes, it is important to know why patients stop therapy before the first dose. High abandonment rates aren’t random; they are caused by things like cost, coverage, confusion, and access problems that are easy to see. Healthcare systems can lower abandonment rates, improve adherence, and make sure that clinical decisions lead to actual, timely treatment by finding these barriers and using connected technology and patient support. The first step toward better health outcomes for patients, doctors, and health systems is not just writing a prescription, but making sure that the prescription becomes therapy.
How MedMonk Helps Bridge the Gap
MedMonk addresses primary non-adherence by supporting patients from the moment a prescription is written through to treatment initiation. Through dedicated patient support programs, MedMonk helps navigate insurance coverage, prior authorizations, copays and financial assistance, pharmacy coordination, and education, removing the practical and financial barriers that often stop patients before the first dose. By combining real-time insights with proactive outreach and financial navigation, MedMonk helps ensure prescriptions don’t stall on paper but translate into timely, affordable treatment for the patients who need it most.
